In breast tumors from cohort 1, higher VMP1 expression level was observed in ERBB2/HER2 positive tumors based on classification with immunohistochemistry (HER2, p = 7x10-4) or molecular subtyping (p = 5x10-6, Fig 2 and Table 2, [38]). This evidence concerns the gene ERBB2 and breast neoplasm.